These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19168559)

  • 1. High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports.
    Bidlingmaier M; Suhr J; Ernst A; Wu Z; Keller A; Strasburger CJ; Bergmann A
    Clin Chem; 2009 Mar; 55(3):445-53. PubMed ID: 19168559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects.
    Okano M; Nishitani Y; Sato M; Ikekita A; Kageyama S
    Drug Test Anal; 2010; 2(11-12):548-56. PubMed ID: 21249726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing.
    Hanley JA; Saarela O; Stephens DA; Thalabard JC
    Growth Horm IGF Res; 2014 Oct; 24(5):205-15. PubMed ID: 24973245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking growth hormone abuse in sport: a comparison of distinct isoform-based assays.
    Bosch J; Ueki M; Such-Sanmartín G; Segura J; Gutiérrez-Gallego R
    Anal Chim Acta; 2012 Jul; 733():56-63. PubMed ID: 22704376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of urinary human growth hormone (hGH) using hydrogel nanoparticles and isoform differential immunoassays after short recombinant hGH treatment: preliminary results.
    Bosch J; Luchini A; Pichini S; Tamburro D; Fredolini C; Liotta L; Petricoin E; Pacifici R; Facchiano F; Segura J; Garaci E; Gutiérrez-Gallego R
    J Pharm Biomed Anal; 2013 Nov; 85():194-7. PubMed ID: 23954438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors.
    Okano M; Nishitani Y; Sato M; Kageyama S
    Drug Test Anal; 2012 Sep; 4(9):692-700. PubMed ID: 22733714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of doping with rhGH: excretion study with WADA-approved kits.
    Jing J; Yang S; Zhou X; He C; Zhang L; Xu Y; Xie M; Yan Y; Su H; Wu M
    Drug Test Anal; 2011; 3(11-12):784-90. PubMed ID: 22147343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of illicit use of growth hormone.
    Stenman UH
    Clin Chem; 2009 Mar; 55(3):387-8. PubMed ID: 19147727
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone.
    Bidlingmaier M; Strasburger CJ
    Handb Exp Pharmacol; 2010; (195):187-200. PubMed ID: 20020365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects.
    Ding J; Okada S; Jørgensen JO; Kopchick JJ
    Proteomics; 2011 Sep; 11(17):3565-71. PubMed ID: 21751372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and protein biomarkers in blood for the improved detection of GH abuse.
    Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
    J Pharm Biomed Anal; 2016 Sep; 128():111-118. PubMed ID: 27243825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
    Di Luigi L; Rigamonti AE; Agosti F; Mencarelli M; Sgrò P; Marazzi N; Cella SG; Müller EE; Sartorio A
    Eur J Endocrinol; 2009 May; 160(5):753-8. PubMed ID: 19258430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker detection of rhGH doping: an excretion study.
    Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
    Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fibronectin 1 in one dried blood spot and in urine after rhGH treatment.
    Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
    Drug Test Anal; 2017 Jul; 9(7):1011-1016. PubMed ID: 27717280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UK Sport perspective on detecting growth hormone abuse.
    Stow MR; Wojek N; Marshall J
    Growth Horm IGF Res; 2009 Aug; 19(4):375-7. PubMed ID: 19487144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human growth hormone doping in sport.
    Saugy M; Robinson N; Saudan C; Baume N; Avois L; Mangin P
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i35-9. PubMed ID: 16799101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of doping with recombinant human growth hormone.
    He C; Wu M
    Bioanalysis; 2009 Aug; 1(5):953-65. PubMed ID: 21083065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNA as a biomarker of human growth hormone administration to patients.
    Kelly BN; Haverstick DM; Lee JK; Thorner MO; Vance ML; Xin W; Bruns DE
    Drug Test Anal; 2014 Mar; 6(3):234-8. PubMed ID: 23495241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.